| |
|
|
| Name: |
Frazier Life Sciences Management L.P. |
| City: |
Menlo Park |
| State: |
CA |
| Zip: |
94025 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
23 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
KRYS |
Krystal Biotech Inc |
2 |
- |
$161.60 |
$175,877,000 |
988,460 |
7.42% |
53,249,000 |
0 |
3.968 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
3 |
- |
$0.00 |
$163,164,000 |
6,495,392 |
6.88% |
-28,580,000 |
0 |
12.118 |
N/A |
|
|
HLVX |
Hillevax, Inc. |
4 |
- |
$12.13 |
$162,666,000 |
9,781,472 |
6.86% |
5,673,000 |
0 |
20.193 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
5 |
- |
$64.97 |
$124,113,000 |
3,131,008 |
5.24% |
64,436,000 |
0 |
4.777 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
6 |
- |
$0.00 |
$107,361,000 |
10,109,279 |
4.53% |
15,063,000 |
0 |
17.658 |
N/A |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
11 |
- |
$0.00 |
$64,977,000 |
1,787,527 |
2.74% |
28,780,000 |
0 |
5.399 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
14 |
- |
$40.75 |
$52,030,000 |
885,165 |
2.2% |
-956,000 |
0 |
0.773 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
15 |
- |
$34.63 |
$48,874,000 |
785,000 |
2.06% |
3,532,000 |
0 |
3.252 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
16 |
- |
$0.00 |
$48,501,000 |
3,014,349 |
2.05% |
-11,424,000 |
0 |
3.736 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
21 |
- |
$0.00 |
$35,628,000 |
1,204,867 |
1.5% |
8,362,000 |
0 |
4.354 |
N/A |
|
|
MRUS |
Merus Nv |
23 |
- |
$57.30 |
$33,614,000 |
746,479 |
1.42% |
13,086,000 |
0 |
1.293 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
24 |
- |
$38.17 |
$32,148,000 |
997,455 |
1.36% |
3,541,000 |
0 |
0.609 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
27 |
- |
$0.00 |
$25,465,000 |
7,381,090 |
1.07% |
15,574,000 |
0 |
12.318 |
N/A |
|
|
ANAB |
Anaptysbio Inc |
31 |
- |
$23.65 |
$20,261,000 |
899,700 |
0.85% |
989,000 |
0 |
2.829 |
N/A |
|
|
SVRA |
Savara Inc |
32 |
- |
$4.11 |
$19,920,000 |
4,000,000 |
0.84% |
1,120,000 |
0 |
2.956 |
Biotechnology |
|
|
CERE |
Cerevel Therapeutics Holdin... |
33 |
- |
$40.64 |
$16,612,000 |
393,000 |
0.7% |
-51,000 |
0 |
0.251 |
N/A |
|
|
AGIO |
Agios Pharmaceuticals Inc |
34 |
- |
$37.54 |
$15,297,000 |
523,166 |
0.65% |
3,646,000 |
0 |
0.757 |
N/A |
|
|
ARVN |
Arvinas Holding Company, Llc |
40 |
- |
$32.24 |
$11,778,000 |
285,331 |
0.5% |
34,000 |
0 |
0.415 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
44 |
- |
$22.10 |
$5,603,000 |
203,684 |
0.24% |
-607,000 |
0 |
0.227 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
45 |
- |
$2.04 |
$4,514,000 |
1,388,889 |
0.19% |
-23,944,000 |
0 |
4.67 |
N/A |
|
|
GRTS |
Gritstone Oncology, Inc. |
47 |
- |
$0.75 |
$2,649,000 |
1,030,878 |
0.11% |
546,000 |
0 |
1.516 |
N/A |
|
|
BLUE |
Bluebird Bio, Inc. |
48 |
- |
$0.90 |
$2,189,000 |
1,709,907 |
0.09% |
-171,000 |
0 |
1.229 |
Biotechnology |
|
|
ACRS |
Aclaris Therapeutics, Inc. |
49 |
- |
$1.05 |
$328,000 |
264,377 |
0.01% |
50,000 |
0 |
0.357 |
N/A |
|
